Alto Neuroscience, Inc.

Historical 13F Holders

Symbol
ANRO
CUSIP
02157Q109
All holders as of
Q2 2026
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 02157Q109 since 12/18/2024, largest first.

Filer % of Class Filed
Perceptive Advisors LLC 13G/A
10.0% 8/14/2026
Event 6/30/2026
Commodore Capital LP 13G/A
9.9% 5/15/2026
Event 3/31/2026
Sirenia Capital Management LP 13G/A
6.2% 8/14/2026
Event 6/30/2026
BlackRock, Inc. 13G 6.0% 7/27/2026
Event 6/30/2026
EcoR1 Capital, LLC 13G
5.8% 7/20/2026
Event 7/13/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Armistice Capital, LLC 13G/A
4.9% 2/18/2026
Event 12/31/2025
FMR LLC 13G/A
4.7% 2/12/2025
Event 12/31/2024
Point72 Asset Management, L.P. 13G/A
3.7% 5/15/2026
Event 3/31/2026
K2 HealthVentures Equity Trust LLC 13G/A
2.4% 2/17/2026
Event 12/31/2025
Vestal Point Capital, LP 13G/A
2.2% 8/14/2026
Event 6/30/2026
RA Capital Management, L.P. 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 12.2 k $313 k
2026 Q2 120 29.5 M $778 M
2026 Q1 114 26.8 M $602 M
2025 Q4 100 24.5 M $436 M
2025 Q3 79 17.0 M $68.2 M
2025 Q2 83 17.3 M $38.1 M
2025 Q1 87 20.8 M $45.0 M
2024 Q4 82 22.5 M $95.3 M
2024 Q3 88 23.0 M $266 M
2024 Q2 62 18.7 M $199 M
2024 Q1 58 16.0 M $246 M